Prevalence of major depressive disorder in people with chemical addiction

Authors

DOI:

https://doi.org/10.11606/issn.1806-6976.smad.2021.173585

Keywords:

Depressive Disorder Major , Substance-Related Disorders, Epidemiology, Rehabilitation

Abstract

Objective: to verify the prevalence of Major Depressive Disorder in people with chemical dependence. Method: cross-sectional study with the application of the structured interview for the DSM-V disorders in 183 individuals admitted to therapeutic communities for chemical dependents, located in the south of Santa Catarina, during the year 2019. Results: All participants did not have a psychiatric consultation when entering the institution and the majority did not have a regular psychiatric consultation (94.5%). It was found that 89 participants (55.3%) had diagnostic criteria for Major Depressive Disorder and 59.1% of these had alcohol addiction (p<0.028). Conclusion: the diagnosis of depressive disorder should be consolidated as an important variable for the effectiveness of treatment, since its prevalence is high and has repercussions on the quality of treatment and time of institutionalization.

Downloads

Download data is not yet available.

References

Hess ARB, Almeida RMM de, Moraes AL. Comorbidity of psychiatric disorders with drug addiction: preliminary results. Estud Psicol. [Internet] 2012 [cited Nov 9, 2020];17(1):171-82. Available from: http://www.redalyc. org/articulo.oa?id=26122929021

Santos IMC, Santiago TRS, Oliveira JRV, Lima DE, Melo MRA. Psychological Evaluation with Users of Psychoactive Substances (SPA): a Systematic Review of Literature. Psi Unisc. 2018;2(1):48-60. doi: https:// dx.doi.org/10.17058/psiunisc.v2i2.10837

Scheffer M, Pasa GG, Almeida MMR. Alcohol, Cocaine, and Crack Dependence and Psychiatric Disorders. Psicol Teor Pesq. 2010;26(3):533–41. doi: https://doi. org/10.1590/S0102-37722010000300016

Heyman GM. Do addicts have free will? An empirical approach to a vexing question. Addict Behaviors Reports. 2017;5:85-93. doi: http://dx.doi.org/10.1016/j. abrep.2017.02.001

Crauss RMG, Abaid JLW. Chemical addiction and the hospital detoxification treatment in the speech of the users. Contextos Clín. 2012;5(1):62-72. doi: http:// dx.doi.org/10.4013/ctc.2012.51.07

Migott AMB. Chemical addiction: a biological, psychological or social problem?. Cad Saúde Pública. 2008;24(3):710-1. doi: https://doi.org/10.1590/ S0102-311X2008000300027

Hasin DS, O’Brien CP, Auriacaombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale. Am J Psychiatry. 2014;170(8):834-51. doi: http://doi. org/10.1176/appi.ajp.2013.12060782

Hoffmann NG, Kopak AM. How well do the DSM-5 alcohol use disorder designations map to the ICD-10 disorders? Alcohol Clin Experiment Res. 2015;39(4):697- 701. doi: https://doi.org/10.1111/acer.12685

Souza AM. Compreensões psicológicas sobre a dependência química. Psicologia.pt. 2017 [cited Nov 9, 2020];1(1)1-17. Available from: https://www.psicologia. pt/artigos/textos/TL0425.pdf

Sebena R, Ansari W, Stock C, Orosova O, Mikolajczyk RT. Are perceived stress, depressive symptoms and religiosity associated with alcohol consumption? A survey of freshmen university students across five European countries. Subst Abus Treat Prev Policy. [Internet]. 2012 [cited Nov 9, 2020];7(1):1-10. Available from: http:// www.substanceabusepolicy.com/content/7/1/21

Cantão L BN. Suicidal behavior among drug addicts. REBEn. 2016;69(2):389-96. doi: http://dx.doi. org/10.1590/0034-7167.2016690224i

Ciribelli EB, Luiz AMAG, Gorayeb R, Domingos NAM, Marques AB Filho. Intervention in waiting room of outpatient clinic addiction: characterization and evaluation of the effects. Temas Psicol. [Internet]. 2016 [cited Nov 9, 2020];16(1):107- 18. Available from: http://pepsic.bvsalud.org/scielo. php?script=sci_arttext&pid=S1413-389X2008000100009

Bastos FI. Epidemiology about chemical dependence in Brasil. NUTE-UFSC. [Internet] 2012 [cited Nov 9, 2020]; 1(1):107-13. Available from: http://aberta.senad.gov.br/

Belsky DW, Moffitt, TE, Corcoran DL, Domingue B, Harrington H, Hogan S, et al. The genetics of success: How single-nucleotide polymorphisms associated with educational attainment relate to life-course development. Psychol Sci. 2016;1(27):957-72. doi: https://doi. org/10.1177/0956797616643070

Presidencia de la Republica del Uruguay. VI Questionnaire National residences on drug use. JND. [Internet] 2016 [cited Nov 9, 2020];1(1):9-115. Available from: http://www.infodrogas.gub.uy/images/stories/ pdf/201609_VI_encuesta_hogares_OUD_ultima_rev.pdf

Quadros LCM, Laura HC, Quevedo LA, Gigante DP. Effects of social mobility on adult mental health:a systematic review of the literature. Ciênc Saúde Coletiva. 2016;21(2):443-8. doi: http://doi. org/10.1590/1413-81232015212.17942014

Sadock BJ, Sadock VA, Ruíz P. Compêndio de psiquiatria: Ciência do comportamento e psiquiatria clínica. Porto Alegre, RS: Artmed; 2016. 1490 p

Gonçalves JS, Silva LL, Abdala GA, Meira MDD, Santos ACM, Silva MFF. Religiosity and common mental disorders in adults. Rev Enferm UFPE online. 2017; 11 (Supl.4):1708-15.doi: 10.5205/ relou.10438-93070-1-RV.1104sup201713

Volkow ND, Koob GF, McLellan T. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363-71. doi: http://doi.org/10.1056/ NEJMra1511480

Volkow ND, Koob G. Brain disease model of addiction: why is it so controversial? Lancet Psychiatry. 2015;2:677- 9. doi: https://doi.org/10.1016/S2215-0366(15)00236-9

Litten RZ, Ryan ML, Falk DE, Reilly M, Fertig JB, Koob GF. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res. 2015;39:579-84. doi: https://doi. org/10.1111/acer.12669

Lemieux A, al’Absi M. Stress psychobiology in the context of addiction medicine: from drugs of abuse to behavioral addictions. Prog Brain Res. 2016;223:43-62. doi: https://doi.org/10.1016/bs.pbr.2015.08.001

Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 2015; 1(1): 1-9. doi: http://doi.org/10.1016/j.biopsych.2015. 10.024

Published

2021-06-30

How to Cite

Pereira, P. M. B., & Bitencourt, R. M. de. (2021). Prevalence of major depressive disorder in people with chemical addiction. SMAD Revista Eletrônica Saúde Mental Álcool E Drogas (Edição Em Português), 17(2), 64-71. https://doi.org/10.11606/issn.1806-6976.smad.2021.173585